ATWLPPR Peptide TFA

Inquiry

Cat. No.: DIA-0243124

Size: 10 mg Size: 25 mg Size: 50 mg Size: 100 mg Size: Customer Size

Product Information
Formula	C₄₂H₆₂F₃N₁₁O₁₁
Molecular Weight	954.00
SMILES	O=C(N[C@@H]([C@H](O)C)C(N[C@@H](CC1=CNC2=CC=CC=C12)C(N[C@@H](CC(C)C)C(N3[C@@H](CCC3)C(N4[C@@H](CCC4)C(N[C@@H](CCCNC(N)=N)C(O)=O)=O)=O)=O)=O)=O)[C@H](C)N.OC(C(F)(F)F)=O
Target	Complement System
Product Description	ATWLPPR Peptide TFA, a heptapeptide, acts as a selective neuropilin-1 inhibitor, inhibits VEGF165 binding to NRP-1, used in the research of angiogenesis. ATWLPPR Peptide TFA has potential in reducing the early retinal damage caused by diabetes.

Format & Storage
Format	Solid
Color	White to off-white
Purity	99.56%
Shipping	Room temperature in the continental U.S. Other areas may vary.
Storage	In solvent: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
Solubility Overview	Soluble in water

All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.